EVAR with No Complications in Octogenarians: Survival Rate Identical to that of Healthy Octogenarians

This analysis reports (for the first time in the literature) that after the endovascular aortic aneurysm repair (EVAR) in octogenarians, survival rate is the same as that of their healthy counterparts.  

Pacientes que no siguen nuestro consejo y sorpresivamente tienen menos eventos

This is true provided the procedure does not present complications. If any, mortality results twice as high in this group. 

Using propensity score, researchers compared octogenarians with identical comorbidities undergoing EVAR vs. others with no aortic aneurysm from the Rotterdam study.

Complications rate for this procedure resulted 27% (mainly cardiac, pulmonary and access complications). This represents twice as many complications than in younger patients, which emphasizes the importance of correct patient selection.


Read also: Another Scandal in Evidence-Based Medicine: Ambulatory BP Monitoring Questioned?


After uncomplicated EVAR, mortality results similar vs the control group in the Rotterdam trial (HR 1.09, CI 95% 0.68 to 1.77). However, should there be any complications, these figures would see a dramatic change (HR 1.93, CI 95% 1.06 to 3.54).

Conclusion

After uncomplicated EVAR in 80+ patients, survival rate is the same as their healthy contemporaries. 

Patient selection and perioperatory care should be carried out thoroughly. 

Original Title: Survival After Uncomplicated EVAR in Octogenarians is Similar to the General Population of Octogenarians Without an Abdominal Aortic Aneurysm.

Reference: Oscar L. Rueda-Ochoa et al. Eur J Vasc Endovasc Surg, article in press.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Aneurysm Sac Regression Predicts Better Clinical Outcomes After EVAR?

Aneurysm sac regression following endovascular abdominal aortic aneurysm repair (EVAR) has been proposed as a marker of favorable remodeling and effective aneurysm exclusion. However,...

SPYRAL Program: 3-Year Outcomes in Patients Treated with Renal Denervation

Hypertension is the leading modifiable risk factor for cardiovascular disease and remains a major global health challenge, affecting more than one billion adults worldwide.  Despite...

Drug-Eluting Stents in Peripheral Arterial Disease: When Should They Be Used?

Peripheral drug-eluting stents have transformed the treatment of peripheral arterial disease by reducing restenosis rates and the need for repeat interventions. However, the emergence...

SCAI 2026 | Deep vein arterialization as an alternative in patients with critical limb ischemia without conventional options

Critical limb ischemia (CLI) represents one of the most advanced stages of peripheral arterial disease (PAD). In a significant proportion of patients, distal anatomy,...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

Prehospital heparin in STEMI: A safe strategy associated with improved early reperfusion

Early reperfusion remains the main prognostic determinant in patients with ST-segment elevation myocardial infarction (STEMI). Although primary percutaneous coronary intervention (PCI) is the treatment...

SAPIEN 3 TAVI Durability: Ten-Year Follow-Up in Intermediate-Risk Patients

The durability of transcatheter bioprosthetic valves used in TAVI remains one of the key unanswered questions as indications continue to expand toward patients with...

Aneurysm Sac Regression Predicts Better Clinical Outcomes After EVAR?

Aneurysm sac regression following endovascular abdominal aortic aneurysm repair (EVAR) has been proposed as a marker of favorable remodeling and effective aneurysm exclusion. However,...